8.43
price down icon13.36%   -1.30
after-market Dopo l'orario di chiusura: 8.42 -0.010 -0.12%
loading
Precedente Chiudi:
$9.73
Aprire:
$9.74
Volume 24 ore:
592.44K
Relative Volume:
5.12
Capitalizzazione di mercato:
$145.52M
Reddito:
$3.25M
Utile/perdita netta:
$-116.80M
Rapporto P/E:
-2.7639
EPS:
-3.05
Flusso di cassa netto:
$-98.17M
1 W Prestazione:
+13.46%
1M Prestazione:
+7.99%
6M Prestazione:
-37.65%
1 anno Prestazione:
-63.54%
Intervallo 1D:
Value
$8.24
$9.84
Intervallo di 1 settimana:
Value
$7.04
$9.84
Portata 52W:
Value
$5.6652
$30.60

Rapt Therapeutics Inc Stock (RAPT) Company Profile

Name
Nome
Rapt Therapeutics Inc
Name
Telefono
(650) 489-9000
Name
Indirizzo
561 ECCLES AVENUE, SOUTH SAN FRANCISCO, CA
Name
Dipendente
67
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-11
Name
Ultimi documenti SEC
Name
RAPT's Discussions on Twitter

Confronta RAPT con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
RAPT
Rapt Therapeutics Inc
8.43 145.52M 3.25M -116.80M -98.17M -3.05
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
441.30 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
521.00 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
322.83 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
560.14 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
241.20 28.51B 3.81B -644.79M -669.77M -6.24

Rapt Therapeutics Inc Stock (RAPT) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-05-22 Ripresa H.C. Wainwright Buy
2024-12-26 Aggiornamento H.C. Wainwright Neutral → Buy
2024-11-13 Downgrade Stifel Buy → Hold
2024-11-11 Downgrade JP Morgan Neutral → Underweight
2024-11-11 Downgrade Piper Sandler Overweight → Neutral
2024-05-14 Downgrade Wolfe Research Outperform → Peer Perform
2024-05-10 Downgrade Barclays Overweight → Equal Weight
2024-05-10 Downgrade Guggenheim Buy → Neutral
2024-02-22 Downgrade UBS Buy → Neutral
2024-02-21 Downgrade H.C. Wainwright Buy → Neutral
2024-02-21 Downgrade JP Morgan Overweight → Neutral
2024-02-21 Downgrade Leerink Partners Outperform → Market Perform
2024-02-20 Downgrade Cantor Fitzgerald Overweight → Neutral
2024-02-16 Iniziato Evercore ISI Outperform
2024-02-15 Iniziato Wolfe Research Outperform
2023-09-14 Iniziato Berenberg Buy
2023-08-09 Iniziato Stifel Buy
2023-06-15 Iniziato Barclays Overweight
2023-01-04 Iniziato Guggenheim Buy
2022-12-01 Iniziato Goldman Buy
2022-09-21 Iniziato CapitalOne Overweight
2022-05-24 Ripresa Cantor Fitzgerald Overweight
2021-12-09 Iniziato JP Morgan Overweight
2021-08-12 Iniziato SVB Leerink Outperform
2021-06-21 Iniziato Piper Sandler Overweight
2020-06-01 Iniziato H.C. Wainwright Buy
2020-05-19 Iniziato Cantor Fitzgerald Overweight
2020-04-13 Iniziato ROTH Capital Buy
2019-11-25 Iniziato BMO Capital Markets Outperform
2019-11-25 Iniziato UBS Buy
2019-11-25 Iniziato Wells Fargo Outperform
Mostra tutto

Rapt Therapeutics Inc Borsa (RAPT) Ultime notizie

pulisher
Jun 18, 2025

Wall Street Analysts Predict a 282.65% Upside in Rapt Therapeutics (RAPT): Here's What You Should Know - Yahoo Finance

Jun 18, 2025
pulisher
Jun 17, 2025

RAPT Therapeutics Executes 1-for-8 Reverse Stock Split - TipRanks

Jun 17, 2025
pulisher
Jun 16, 2025

RAPT Therapeutics (RAPT) Trading Halted as News Awaits Release | RAPT Stock News - GuruFocus

Jun 16, 2025
pulisher
Jun 16, 2025

Layoff Tracker: Gilead Cuts 36 Employees in California - BioSpace

Jun 16, 2025
pulisher
Jun 14, 2025

Rapt Therapeutics announces effective date for 1-for-8 reverse stock split - Yahoo Finance

Jun 14, 2025
pulisher
Jun 13, 2025

# RAPT Therapeutics to implement 1-for-8 reverse stock split By Investing.com - Investing.com South Africa

Jun 13, 2025
pulisher
Jun 13, 2025

RAPT Finalizes Reverse Split Plan; 1-for-8 Ratio Effective June 16, 2025 - Nasdaq

Jun 13, 2025
pulisher
Jun 13, 2025

RAPT Therapeutics Shares to Start Trading on a Split-Adjusted Basis Tuesday - marketscreener.com

Jun 13, 2025
pulisher
Jun 13, 2025

RAPT Therapeutics Announces Effective Date For 1-For-8 Reverse Stock Split - MarketScreener

Jun 13, 2025
pulisher
Jun 13, 2025

RAPT Therapeutics Announces Reverse Stock Split Effective June 2025 | RAPT Stock News - GuruFocus

Jun 13, 2025
pulisher
Jun 13, 2025

# RAPT Therapeutics to implement 1-for-8 reverse stock split - Investing.com

Jun 13, 2025
pulisher
Jun 13, 2025

RAPT Therapeutics Announces Effective Date for 1-for-8 Reverse Stock Split - GlobeNewswire

Jun 13, 2025
pulisher
Jun 13, 2025

RAPT Therapeutics Announces Major Share Consolidation: 132M Shares Shrinking to 16.5M in Reverse Split - Stock Titan

Jun 13, 2025
pulisher
Jun 12, 2025

Two Sigma Investments LP Sells 339,957 Shares of RAPT Therapeutics, Inc. (NASDAQ:RAPT) - Defense World

Jun 12, 2025
pulisher
Jun 10, 2025

Transcript : RAPT Therapeutics, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 09 - MarketScreener

Jun 10, 2025
pulisher
Jun 09, 2025

Rapt Therapeutics Get A Bullish Recommendation On ‘Significant Opportunity’ For Allergy Drug Candidate: Retail Worries About Cash Position - MSN

Jun 09, 2025
pulisher
Jun 09, 2025

RAPT Therapeutics Announces Development Plans for RPT904 - TipRanks

Jun 09, 2025
pulisher
Jun 09, 2025

Jane Street Group LLC Sells 29,821 Shares of RAPT Therapeutics, Inc. (NASDAQ:RAPT) - Defense World

Jun 09, 2025
pulisher
Jun 07, 2025

Nuveen Asset Management LLC Buys 39,216 Shares of RAPT Therapeutics, Inc. (NASDAQ:RAPT) - Defense World

Jun 07, 2025
pulisher
Jun 06, 2025

RAPT Therapeutics (RAPT) Has a New Rating from Clear Street - The Globe and Mail

Jun 06, 2025
pulisher
Jun 05, 2025

Rapt Therapeutics Get A Bullish Recommendation On ‘Significant Opportunity’ For Allergy Drug Candidate: Retail Worries About Cash Position By Stocktwits - Investing.com India

Jun 05, 2025
pulisher
Jun 05, 2025

Clear Street initiates Rapt Therapeutics stock with buy rating By Investing.com - Investing.com UK

Jun 05, 2025
pulisher
Jun 05, 2025

Clear Street Initiates Coverage on Rapt Therapeutics (RAPT) with Buy Rating | RAPT Stock News - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

Millennium Management LLC Sells 222,261 Shares of RAPT Therapeutics, Inc. (NASDAQ:RAPT) - Defense World

Jun 05, 2025
pulisher
Jun 04, 2025

RAPT Therapeutics to Participate in Upcoming Investor Conferences - The Manila Times

Jun 04, 2025
pulisher
Jun 04, 2025

RAPT Therapeutics Management to Share Latest Immunology Pipeline Updates at Major Healthcare Conferences - Stock Titan

Jun 04, 2025
pulisher
Jun 03, 2025

RAPT Therapeutics, Inc. (NASDAQ:RAPT) Receives Consensus Recommendation of “Hold” from Brokerages - Defense World

Jun 03, 2025
pulisher
May 28, 2025

RAPT Therapeutics Faces Nasdaq Delisting Notice - TipRanks

May 28, 2025
pulisher
May 26, 2025

What is HC Wainwright’s Forecast for RAPT Q2 Earnings? - Defense World

May 26, 2025
pulisher
May 25, 2025

UBS Group Cuts RAPT Therapeutics (NASDAQ:RAPT) Price Target to $1.00 - Defense World

May 25, 2025
pulisher
May 24, 2025

RAPT Therapeutics (NASDAQ:RAPT) Stock Rating Upgraded by HC Wainwright - Defense World

May 24, 2025
pulisher
May 23, 2025

D. E. Shaw & Co. Inc. Sells 278,173 Shares of RAPT Therapeutics, Inc. (NASDAQ:RAPT) - Defense World

May 23, 2025
pulisher
May 22, 2025

RAPT Stock: HC Wainwright & Co. Announces New Price Target | RAP - GuruFocus

May 22, 2025
pulisher
May 22, 2025

UBS Adjusts Price Target for Rapt Therapeutics (RAPT) | RAPT Stock News - GuruFocus

May 22, 2025
pulisher
May 22, 2025

RAPT Analyst Update: UBS Adjusts Price Target to $1 | RAPT Stock News - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Rapt Therapeutics (RAPT) Receives Buy Rating with Promising Outl - GuruFocus

May 22, 2025
pulisher
May 22, 2025

UBS Adjusts Price Target for Rapt Therapeutics (RAPT) | RAPT Sto - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Rapt Therapeutics (RAPT) Receives Buy Rating with Promising Outlook | RAPT Stock News - GuruFocus

May 22, 2025
pulisher
May 22, 2025

UBS cuts Rapt Therapeutics stock target to $1 from $2 By Investing.com - Investing.com UK

May 22, 2025
pulisher
May 19, 2025

Comerica Bank Purchases Shares of 58,040 RAPT Therapeutics, Inc. (NASDAQ:RAPT) - Defense World

May 19, 2025
pulisher
May 18, 2025

Dimensional Fund Advisors LP Sells 105,231 Shares of RAPT Therapeutics, Inc. (NASDAQ:RAPT) - Defense World

May 18, 2025
pulisher
May 16, 2025

Rapt Therapeutics (RAPT) Upgraded to Buy: Here's What You Should Know - Yahoo Finance

May 16, 2025
pulisher
May 09, 2025

RAPT Therapeutics, Inc. (RAPT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings - ACCESS Newswire

May 09, 2025
pulisher
May 09, 2025

RAPT Therapeutics, Inc. (NASDAQ:RAPT) Given Average Rating of “Hold” by Analysts - Defense World

May 09, 2025
pulisher
May 09, 2025

RAPT Therapeutics Reports Improved Q1 2025 Results - TipRanks

May 09, 2025
pulisher
May 08, 2025

RAPT Therapeutics Reports First Quarter 2025 Financial Results - GlobeNewswire

May 08, 2025
pulisher
May 08, 2025

RAPT Therapeutics, Inc. SEC 10-Q Report - TradingView

May 08, 2025
pulisher
May 05, 2025

RAPT Therapeutics Reports Third Quarter 2024 Financial Results - ADVFN

May 05, 2025
pulisher
May 05, 2025

RAPT Therapeutics Inc expected to post a loss of 13 cents a shareEarnings Preview - TradingView

May 05, 2025
pulisher
May 04, 2025

RAPTRapt Therapeutics, Inc. Latest Stock News & Market Updates - Stock Titan

May 04, 2025
pulisher
May 04, 2025

Renaissance Technologies LLC Has $584,000 Stock Position in RAPT Therapeutics, Inc. (NASDAQ:RAPT) - Defense World

May 04, 2025

Rapt Therapeutics Inc Azioni (RAPT) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$20.50
price down icon 1.11%
$35.87
price up icon 1.70%
$20.60
price down icon 3.38%
$99.49
price down icon 2.21%
$106.72
price up icon 0.55%
biotechnology ONC
$241.20
price down icon 5.22%
Capitalizzazione:     |  Volume (24 ore):